Abstract
1. The serotonin(2C) (5-HT(2C)) receptor couples to both phospholipase C (PLC)-inositol phosphate (IP) and phospholipase A(2) (PLA(2))-arachidonic acid (AA) signalling cascades. Agonists can differentially activate these effectors (i.e. agonist-directed trafficking of receptor stimulus) perhaps due to agonist-specific receptor conformations which differentially couple to/activate transducer molecules (e.g. G proteins). Since editing of RNA transcripts of the human 5-HT(2C) receptor leads to substitution of amino acids at positions 156, 158 and 160 of the putative second intracellular loop, a region important for G protein coupling, we examined the capacity of agonists to activate both the PLC-IP and PLA(2)-AA pathways in CHO cells stably expressing two major, fully RNA-edited isoforms (5-HT(2C-VSV), 5-HT(2C-VGV)) of the h5-HT(2C) receptor. 2. 5-HT increased AA release and IP accumulation in both 5-HT(2C-VSV) and 5-HT(2C-VGV) expressing cells. As expected, the potency of 5-HT for both RNA-edited isoforms for both responses was 10 fold lower relative to that of the non-edited receptor (5-HT(2C-INI)) when receptors were expressed at similar levels. 3. Consistent with our previous report, the efficacy order of two 5-HT receptor agonists (TFMPP and bufotenin) was reversed for AA release and IP accumulation at the non-edited receptor thus demonstrating agonist trafficking of receptor stimulus. However, with the RNA-edited receptor isoforms there was no difference in the relative efficacies of TFMPP or bufotenin for AA release and IP accumulation suggesting that the capacity for 5-HT(2C) agonists to traffic receptor stimulus is lost as a result of RNA editing. 4. These results suggest an important role for the second intracellular loop in transmitting agonist-specific information to signalling molecules.
MeSH Terms
Amphetamines/pharmacology
Animals
Arachidonic Acid/metabolism
Binding, Competitive/drug effects
Bufotenin/pharmacology
CHO Cells
Cricetinae
Dose-Response Relationship, Drug
Ergolines/metabolism
Inositol Phosphates/metabolism
Lysergic Acid Diethylamide/pharmacology
Piperazines/pharmacology
Protein Isoforms/genetics,metabolism
Quipazine/pharmacology
RNA Editing
Radioligand Assay
Receptor, Serotonin, 5-HT2C
Receptors, Serotonin/genetics,metabolism
Serotonin/pharmacology
Serotonin Receptor Agonists/metabolism,pharmacology
Tritium
Chemicals
Amphetamines
Ergolines
Inositol Phosphates
Piperazines
Protein Isoforms
Receptor, Serotonin, 5-HT2C
Receptors, Serotonin
Serotonin Receptor Agonists
Bufotenin
Tritium
1-(3-trifluoromethylphenyl)piperazine
Arachidonic Acid
Serotonin
Quipazine
Lysergic Acid Diethylamide
4-iodo-2,5-dimethoxyphenylisopropylamine
mesulergine
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Berg K A
Department of Pharmacology, Mail Code 7764, University of Texas Health Science Center, San Antonio, Texas, TX 78229-3900, USA. berg@uthscsa.edu
Cropper J D
Niswender C M
Sanders-Bush E
Emeson R B
Clarke W P
References (26)
26 references, click to expand
-
Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD).
Neuropsychopharmacology. 1999 Aug;21(2 Suppl):77S-81S
PMID: 10432492
-
Differential involvement of Galpha12 and Galpha13 in receptor-mediated stress fiber formation.
J Biol Chem. 1999 Jun 18;274(25):17901-7
PMID: 10364236
-
Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction.
J Neurochem. 1999 Oct;73(4):1711-7
PMID: 10501219
-
Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides. Endogenous 5-HT(2C) receptors in choroid plexus epithelial cells.
J Biol Chem. 2000 Mar 10;275(10):7021-9
PMID: 10702266
-
Agonist-directed trafficking of porcine alpha(2A)-adrenergic receptor signaling in Chinese hamster ovary cells: l-isoproterenol selectively activates G(s).
J Pharmacol Exp Ther. 2000 Aug;294(2):539-47
PMID: 10900230
-
Influence of receptor number on functional responses elicited by agonists acting at the human adenosine A(1) receptor: evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity.
Mol Pharmacol. 2000 Nov;58(5):1075-84
PMID: 11040056
-
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108
PMID: 4202581
-
A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover.
Proc Natl Acad Sci U S A. 1986 Jun;83(11):4086-8
PMID: 2940597
-
Differential signal transduction by five splice variants of the PACAP receptor.
Nature. 1993 Sep 9;365(6442):170-5
PMID: 8396727
-
Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems.
EMBO J. 1994 Mar 15;13(6):1325-30
PMID: 8137817
-
Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
Mol Pharmacol. 1994 Sep;46(3):477-84
PMID: 7935328
-
Serotonin 5-HT2C receptor stimulates cyclic GMP formation in choroid plexus.
J Neurochem. 1995 Jan;64(1):199-205
PMID: 7798914
-
Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.
Trends Pharmacol Sci. 1995 Jul;16(7):232-8
PMID: 7667897
-
RNA editing.
Annu Rev Neurosci. 1996;19:27-52
PMID: 8833435
-
5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism.
Mol Pharmacol. 1996 Oct;50(4):1017-23
PMID: 8863849
-
Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding.
Br J Pharmacol. 1996 Mar;117(6):1119-26
PMID: 8882605
-
Functional and structural complexity of signal transduction via G-protein-coupled receptors.
Annu Rev Neurosci. 1997;20:399-427
PMID: 9056720
-
Regulation of serotonin-2C receptor G-protein coupling by RNA editing.
Nature. 1997 May 15;387(6630):303-8
PMID: 9153397
-
A guide to RNA editing.
RNA. 1997 Oct;3(10):1105-23
PMID: 9326486
-
Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.
Mol Pharmacol. 1998 Jul;54(1):94-104
PMID: 9658194
-
The elusive nature of intrinsic efficacy.
Trends Pharmacol Sci. 1998 Jul;19(7):270-6
PMID: 9703760
-
5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function.
Pharmacol Ther. 1998 Sep;79(3):231-57
PMID: 9776378
-
RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity.
J Biol Chem. 1999 Apr 2;274(14):9472-8
PMID: 10092629
-
Novel actions of inverse agonists on 5-HT2C receptor systems.
Mol Pharmacol. 1999 May;55(5):863-72
PMID: 10220565
-
Heptahelical receptor signaling: beyond the G protein paradigm.
J Cell Biol. 1999 May 31;145(5):927-32
PMID: 10352011
-
Messenger RNA editing of the human serotonin 5-HT2C receptor.
Neuropsychopharmacology. 1999 Aug;21(2 Suppl):82S-90S
PMID: 10432493